Literature DB >> 22354795

Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity.

Kevin D Deane.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22354795      PMCID： PMC4527318          DOI： 10.1002/art.34445

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  30 in total

1.  The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner.

Authors:  Kevin D Deane; Colin I O'Donnell; Wolfgang Hueber; Darcy S Majka; Ann A Lazar; Lezlie A Derber; William R Gilliland; Jess D Edison; Jill M Norris; William H Robinson; V Michael Holers
Journal:  Arthritis Rheum       Date:  2010-11

2.  Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.

Authors:  S Rantapää-Dahlqvist; K Boman; A Tarkowski; G Hallmans
Journal:  Ann Rheum Dis       Date:  2006-06-01       Impact factor: 19.103

3.  A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.

Authors:  Jason R Kolfenbach; Kevin D Deane; Lezlie A Derber; Colin O'Donnell; Michael H Weisman; Jane H Buckner; Vivian H Gersuk; Shan Wei; Ted R Mikuls; James O'Dell; Peter K Gregersen; Richard M Keating; Jill M Norris; V Michael Holers
Journal:  Arthritis Rheum       Date:  2009-12-15

4.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Authors:  Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij
Journal:  Arthritis Rheum       Date:  2003-10

5.  Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis.

Authors:  Lori B Chibnik; Lisa A Mandl; Karen H Costenbader; Peter H Schur; Elizabeth W Karlson
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

6.  Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.

Authors:  K T Jørgensen; A Wiik; M Pedersen; C J Hedegaard; B F Vestergaard; R E Gislefoss; T K Kvien; J Wohlfahrt; K Bendtzen; M Frisch
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

7.  Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies.

Authors:  Elizabeth W Karlson; Lori B Chibnik; Shelley S Tworoger; I-Min Lee; Julie E Buring; Nancy A Shadick; Joann E Manson; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-03

8.  Multiplex, megaplex, index, and complex: the present and future of laboratory diagnostics in rheumatology.

Authors:  Mark H Wener
Journal:  Arthritis Res Ther       Date:  2011-11-24       Impact factor: 5.156

9.  EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis.

Authors:  Danielle M Gerlag; Karim Raza; Lisa G M van Baarsen; Elisabeth Brouwer; Christopher D Buckley; Gerd R Burmester; Cem Gabay; Anca I Catrina; Andrew P Cope; François Cornelis; Solbritt Rantapää Dahlqvist; Paul Emery; Stephen Eyre; Axel Finckh; Steffen Gay; Johanna M Hazes; Annette van der Helm-van Mil; Tom W J Huizinga; Lars Klareskog; Tore K Kvien; Cathryn Lewis; Klaus P Machold; Johan Rönnelid; Dirkjan van Schaardenburg; Georg Schett; Josef S Smolen; Sue Thomas; Jane Worthington; Paul P Tak
Journal:  Ann Rheum Dis       Date:  2012-03-02       Impact factor: 19.103

10.  A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

Authors:  Ewa Berglin; Leonid Padyukov; Ulf Sundin; Göran Hallmans; Hans Stenlund; Walther J Van Venrooij; Lars Klareskog; Solbritt Rantapää Dahlqvist
Journal:  Arthritis Res Ther       Date:  2004-05-11       Impact factor: 5.156
View more
  5 in total

1.  The preclinical phase of PsA: a challenge for the epidemiologist.

Authors:  Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2017-03-08       Impact factor: 19.103

2.  Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?

Authors:  Sonia Unriza-Puin; Wilson Bautista-Molano; Gloria I Lafaurie; Rafael Valle-Oñate; Philippe Chalem; Lorena Chila-Moreno; Juan Manuel Bello-Gualtero; Consuelo Romero-Sánchez
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

Review 3.  Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.

Authors:  William P Arend; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

4.  Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.

Authors:  Yanxia Guo; Alice M Walsh; Mary Canavan; Mihir D Wechalekar; Suzanne Cole; Xuefeng Yin; Brittney Scott; Mathew Loza; Carl Orr; Trudy McGarry; Michele Bombardieri; Frances Humby; Susanna M Proudman; Costantino Pitzalis; Malcolm D Smith; Joshua R Friedman; Ian Anderson; Loui Madakamutil; Douglas J Veale; Ursula Fearon; Sunil Nagpal
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

5.  Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Authors:  Jan Vollert; Nancy R Cook; Ted J Kaptchuk; Shiv T Sehra; Deirdre K Tobias; Kathryn T Hall
Journal:  JAMA Netw Open       Date:  2020-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.